- Q1 2024 Cellectis SA Earnings Call TranscriptMay 29, 2024€2.52 (-1.56%)Earnings
- Q3 2023 Cellectis SA Earnings Call TranscriptNov 07, 2023€2.08 (-17.46%)Earnings
- Cellectis SA at Jefferies Cell & Genetic Medicine Summit TranscriptSep 26, 2023
- Q2 2023 Cellectis SA Earnings Call TranscriptAug 04, 2023€1.71 (+1.79%)Earnings
- Cellectis SA at Goldman Sachs Healthcare Conference TranscriptJun 15, 2023
- Q1 2023 Cellectis SA Earnings Call TranscriptMay 05, 2023€1.63 (+1.24%)Earnings
- Cellectis SA at Barclays Global Healthcare Conference TranscriptMar 14, 2023
- Q4 2022 Cellectis SA Earnings Call TranscriptMar 09, 2023€1.95Earnings
- Cellectis SA Corporate Analyst Meeting (Virtual) TranscriptDec 13, 2022
- Q3 2022 Cellectis SA Earnings Call TranscriptNov 04, 2022€2.38 (-3.25%)Earnings
- Atara Biotherapeutics Inc, Cellectis SA and 2Seventy Bio Inc at Citi BioPharma Conference- Panel TranscriptSep 07, 2022
- Q2 2022 Cellectis SA Earnings Call TranscriptAug 05, 2022€2.92 (-5.81%)Earnings
- Cellectis SA at Goldman Sachs Global Healthcare Conference TranscriptJun 16, 2022
- Cellectis SA at JMP Securities Life Sciences Conference TranscriptJun 16, 2022
- Q1 2022 Cellectis SA Earnings Call TranscriptMay 13, 2022€2.84 (+9.23%)Earnings
- Cellectis SA at Barclays Global Healthcare Conference TranscriptMar 17, 2022
- Q4 2021 Cellectis SA Earnings Call TranscriptMar 04, 2022€3.32 (-6.74%)Earnings
- Cellectis SA at Barclays Gene Editing & Gene Therapy Summit (Virtual) TranscriptNov 15, 2021
- Q3 2021 Cellectis SA Earnings Call TranscriptNov 05, 2021€10.5 (-1.87%)Earnings
- Cellectis SA at Citi BioPharma Conference (Virtual) TranscriptSep 09, 2021
- Q2 2021 Cellectis SA Earnings Call TranscriptAug 06, 2021€11.3 (+3.67%)Earnings
- Cellectis SA at Barclays Global Healthcare Conference (Virtual) TranscriptMar 10, 2021
- Q4 2020 Cellectis SA Earnings Call TranscriptMar 05, 2021€15.8 (-3.07%)Earnings
- Cellectis SA at Barclays Virtual Gene Editing & Gene Therapy Summit - Presentation TranscriptNov 16, 2020
- Q3 2020 Cellectis SA Earnings Call TranscriptNov 06, 2020€15.1 (+8.63%)Earnings
- Cellectis SA at Bank of America Merrill Lynch Global Healthcare Conference (Virtual) TranscriptSep 17, 2020
- Q2 2020 Cellectis SA Earnings Call TranscriptAug 06, 2020€14.8 (+2.78%)Earnings
- Cellectis SA Chardan Leadership Call TranscriptMay 27, 2020
- Q1 2020 Cellectis SA Earnings Call TranscriptMay 07, 2020€12.8 (-1.54%)Earnings
- Q4 2019 Cellectis SA Earnings Call TranscriptMar 05, 2020€14Earnings
- Q3 2019 Cellectis SA Earnings Call TranscriptNov 07, 2019€11.3 (+2.73%)Earnings
- Cellectis SA at Citi Biotech Conference TranscriptSep 04, 2019
- Cellectis SA at Goldman Sachs Global Healthcare Conference TranscriptJun 13, 2019
- Cellectis SA at Barclays Global Healthcare Conference TranscriptMar 13, 2019
- Q4 2018 Cellectis SA Earnings Call TranscriptMar 12, 2019€16.1 (+1.26%)Earnings
Cellectis SA Corporate Analyst Meeting (Virtual) Transcript
Good morning, and welcome to the Cellectis Clinical Update. (Operator Instructions) As a reminder, this call is being recorded, and a replay will be made available on the Cellectis website following the conclusion of the event.
I'd now like to turn the call over to Andre Choulika, Chief Executive Officer of Cellectis. Please go ahead, Andre.
Well, thank you very much, and welcome, everyone. Thank you very much for waking up early this morning to attend this webcast. We're really excited to present some update on our AMELI trial, UCART123, and our BALLI trial, UCART22, that will be presented by Mark after. Before this, I will give you a quick introduction of the company. If I can have the next slide, please.
I would like you to read carefully. I'll give you a few minutes to read carefully the legal notice on the disclaimer. Thank you. So a quick overview of Cellectis. Cellectis at the glance gives you a quick idea of what we are at. Cellectis have 4 ongoing clinical trials with
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)